1st May 2026Latest Possible Start Date: 3-month notice period consideredPlanned Duration of Employment: 12 monthsMax. Pay Rate: 57.37 CHF per hourWorkplace: Basel on siteWorkload: 100%Home Office: No;
only on exceptionsTravel: NoBackgroundWe're currently looking for a research associate to assess efficacy, safety and translatability of gene therapies in nonmalignant hematology (bleeding/thrombotic disorders, anemia, etc..) by using different in vivo and ex vivo assays. Together with a larger team you will work with preclinical animal models and human patient material (blood and plasma) and characterize different gene therapy assets in hemostasis and thrombosis. The ex vivo and in vivo approaches will require you to be skilled in end-to-end experiments from the hands-on animal study, sample collection to different ex vivo assays.The Perfect CandidateMSc/BSc in Life Sciences or completed apprenticeship with hands-on study experience, an active LTK1 (or FELASA equivalent) certification and proven experience in rodent work, including intravenous injections and blood collection, to support in vivo gene therapy studies in a collaborative research environment. Experience in molecular and biochemical assays, coagulation biology, and industrial research settings is preferred, along with strong organizational skills, fluency in English, and a proactive, team-oriented mindset.Tasks & Responsibilities- Design, execute, and analyze diverse in vivo experiments, including intravenous injections, blood and plasma collection, bleeding and thrombosis models, and related procedures- Characterize efficacy and safety of novel gene therapy assets using molecular and biochemical assays (e.G., ELISA, thrombin generation assay, chromogenic assays) in murine and human samples- Prepare, handle, and test patient-derived material (blood and plasma) in in vitro and ex vivo settings- Perform data analysis and present results within the team- Maintain thorough documentation and contribute to general lab organization, safety, and inventory management
